{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:43:26Z","timestamp":1784634206532,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Clinical Medical Research Transformation Special Project of Anhui Province","award":["No. 202204295107020051"],"award-info":[{"award-number":["No. 202204295107020051"]}]},{"name":"the Co-construction Project of the Bengbu Municipal Health Commission","award":["No. BBWK2024A105"],"award-info":[{"award-number":["No. BBWK2024A105"]}]},{"name":"the Excellent Scientific Research and Innovation Team of Anhui Universities","award":["No. 2024AH010021"],"award-info":[{"award-number":["No. 2024AH010021"]}]},{"name":"the open project fund of Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical University","award":["No. KFKT202514"],"award-info":[{"award-number":["No. KFKT202514"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15796-8","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:04:25Z","timestamp":1772172265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["AHSP as a novel non-invasive urinary biomarker for prostate cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Chen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-qun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-nan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-lun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"15796_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"15796_CR2","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1056\/NEJMoa2407934","volume":"392","author":"JK McHugh","year":"2025","unstructured":"McHugh JK, Bancroft EK, Saunders E, Brook MN, McGrowder E, Wakerell S, et al. Assessment of a polygenic risk score in screening for prostate cancer. N Engl J Med. 2025;392:1406\u201317.","journal-title":"N Engl J Med"},{"key":"15796_CR3","unstructured":"Cancer Research UK. Prostate cancer statistics. Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/prostate-cancer. Accessed 20 Nov 2025."},{"key":"15796_CR4","doi-asserted-by":"crossref","unstructured":"Feng S, Khan R, Lee S, Kim SJ, Kim T, Lee YJ. MXene\/PEDOT:PSS-based dual-biomarker impedimetric immunosensor for accurate differentiation of prostate cancer from BPH through urinary detection. Biosens Bioelectron 2025, 117888.","DOI":"10.1016\/j.bios.2025.117888"},{"key":"15796_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12185-019-02806-8","volume":"111","author":"NS Che Yaacob","year":"2020","unstructured":"Che Yaacob NS, Islam MA, Alsaleh H, Ibrahim IK, Hassan R. Alpha-hemoglobin-stabilizing protein (AHSP): a modulatory factor in \u03b2-thalassemia. Int J Hematol. 2020;111:352\u20139.","journal-title":"Int J Hematol"},{"key":"15796_CR6","doi-asserted-by":"publisher","first-page":"14311","DOI":"10.3389\/bjbs.2025.14311","volume":"82","author":"M Zurlo","year":"2025","unstructured":"Zurlo M, Finotti A, Gamberini MR, Gambari R. Co-induction of ULK-1 and AHSP mRNAs in erythroid precursor cells isolated from a sirolimus-treated \u03b2-thalassemia patient: a case report study. Br J Biomed Sci. 2025;82:14311.","journal-title":"Br J Biomed Sci"},{"key":"15796_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2004.11.025","volume":"119","author":"L Feng","year":"2004","unstructured":"Feng L, Gell DA, Zhou S, Gu L, Kong Y, Li J, et al. Molecular mechanism of AHSP-mediated stabilization of \u03b1-hemoglobin. Cell. 2004;119:629\u201340.","journal-title":"Cell"},{"key":"15796_CR8","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature00803","volume":"417","author":"AJ Kihm","year":"2002","unstructured":"Kihm AJ, Kong Y, Hong W, Russell JE, Rouda S, Adachi K, et al. An abundant erythroid protein that stabilizes free \u03b1-haemoglobin. Nature. 2002;417:758\u201363.","journal-title":"Nature"},{"issue":"9","key":"15796_CR9","doi-asserted-by":"publisher","first-page":"e0274463","DOI":"10.1371\/journal.pone.0274463","volume":"17","author":"N Mikhaylenko","year":"2022","unstructured":"Mikhaylenko N, Wahnschaffe L, Herling M, Roeder I, Seifert M. Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia. PLoS ONE. 2022;17(9):e0274463. https:\/\/doi.org\/10.1371\/journal.pone.0274463.","journal-title":"PLoS ONE"},{"key":"15796_CR10","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1159\/000479837","volume":"42","author":"GZ Zhu","year":"2017","unstructured":"Zhu GZ, Yang YL, Zhang YJ, Liu W, Li MP, Zeng WJ, et al. High expression of AHSP, EPB42, GYPC and HEMGN predicts favorable prognosis in FLT3-ITD-negative acute myeloid leukemia. Cell Physiol Biochem. 2017;42:1973\u201384.","journal-title":"Cell Physiol Biochem"},{"key":"15796_CR11","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3390\/biomedicines13081845","volume":"13","author":"T Bin","year":"2025","unstructured":"Bin T, Wang Y, Tang J, Xu XJ, Lin C, Lu B. Prognostic risk model of megakaryocyte\u2013erythroid progenitor (MEP) signature based on AHSP and MYB in acute myeloid leukemia. Biomedicines. 2025;13:1845.","journal-title":"Biomedicines"},{"key":"15796_CR12","first-page":"766","volume":"32","author":"H Hua","year":"2025","unstructured":"Hua H, Tao S, Yu N, Zhu Y, Shen J, Gong Y, et al. ACSM1 and LIF expression and their prognostic significance in prostate cancer. Diagn Pathol J China. 2025;32:766\u201372. (in Chinese).","journal-title":"Diagn Pathol J China"},{"key":"15796_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/PAI.0000000000000139","volume":"24","author":"H Yu","year":"2016","unstructured":"Yu H, Pinkus JL, Pinkus GS. \u03b1-Hemoglobin-stabilizing protein: an effective marker for erythroid precursors in bone marrow biopsy specimens. Appl Immunohistochem Mol Morphol. 2016;24:51\u20136.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"15796_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1210\/er.2002-0032","volume":"25","author":"CA Heinlein","year":"2004","unstructured":"Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev. 2004;25:276\u2013308.","journal-title":"Endocr Rev"},{"key":"15796_CR15","first-page":"BSR20253197","volume":"45","author":"K Yavuz","year":"2025","unstructured":"Yavuz K, Lack NA. Coregulators determine androgen receptor activity in prostate cancer. Biosci Rep. 2025;45:BSR20253197.","journal-title":"Biosci Rep"},{"key":"15796_CR16","doi-asserted-by":"publisher","first-page":"T179","DOI":"10.1530\/ERC-16-0422","volume":"23","author":"I Coutinho","year":"2016","unstructured":"Coutinho I, Day TK, Tilley WD, Selth LA. Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence. Endocr Relat Cancer. 2016;23:T179\u201397.","journal-title":"Endocr Relat Cancer"},{"key":"15796_CR17","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1073\/pnas.83.10.3500","volume":"83","author":"B Wiedenmann","year":"1986","unstructured":"Wiedenmann B, Franke WW, Kuhn C, Moll R, Gould VE. Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci U S A. 1986;83:3500\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"15796_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000051853","volume":"62","author":"B Eriksson","year":"2000","unstructured":"Eriksson B, \u00d6berg K, Stridsberg M. Tumor markers in neuroendocrine tumors. Digestion. 2000;62(Suppl 1):33\u20138.","journal-title":"Digestion"},{"key":"15796_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10:63\u201389.","journal-title":"World J Oncol"},{"key":"15796_CR20","unstructured":"American Cancer Society. American Cancer Society recommendations for prostate cancer early detection. Available from: https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/detection-diagnosis-staging\/acs-recommendations.html. Accessed 20 Nov 2025."},{"key":"15796_CR21","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70028","author":"TB Kratzer","year":"2025","unstructured":"Kratzer TB, Mazzitelli N, Star J, Dahut WL, Jemal A, Siegel RL. Prostate cancer statistics, 2025. CA Cancer J Clin. 2025. https:\/\/doi.org\/10.3322\/caac.70028. Epub ahead of print.","journal-title":"CA Cancer J Clin"},{"key":"15796_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00345-016-1900-9","volume":"35","author":"P Lunardi","year":"2017","unstructured":"Lunardi P, Ploussard G, Grosclaude P, Roumigui\u00e9 M, Souli\u00e9 M, Beauval JB, et al. Current impact of age and comorbidity assessment on prostate cancer treatment choice and over-\/undertreatment risk. World J Urol. 2017;35:587\u201393.","journal-title":"World J Urol"}],"updated-by":[{"DOI":"10.1186\/s12885-026-16260-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15796-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15796-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15796-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:58:24Z","timestamp":1780300704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15796-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15796"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15796-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated: data in the \u201cUrinary ELISA\u201d subsection of the Materials and Methods has been updated","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12885-026-16260-3","URL":"https:\/\/doi.org\/10.1186\/s12885-026-16260-3","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Third People\u2019s Hospital of Bengbu (Approval No. 2023-01). The study was conducted in accordance with the ethical standards of the institutional ethics committee and the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. As a retrospective investigation using archived pathological specimens and de-identified clinical and laboratory data, this study did not involve the disclosure of any personally identifiable information, and no therapeutic interventions were influenced during data collection. In view of these characteristics, the Ethics Committee waived the requirement for written informed consent from the participants in accordance with relevant national regulations and institutional policies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"574"}}